[MS26] Mini Symposium 26
Treatment for adult asthma 2

[MS26-4] Long-term safety of once-daily single inhaler triple therapy with fluticasone furoate/umeclidinium/vilanterol in Japanese patients with asthma: a Phase III open-label study

Soichiro Hozawa¹, Hiroyuki Ohbayashi², Andrew Fowler³, Laurie Lee⁴, Takashi Nakayama⁵ (1.Hiroshima Allergy and Respiratory Clinic, Japan, 2.Tohno Chuo Clinic, Japan, 3.GlaxoSmithKline, UK, 4.GlaxoSmithKline, USA, 5.GlaxoSmithKline K.K., Japan)